310 related articles for article (PubMed ID: 3018660)
21. Herpes simplex virus-specific human cytotoxic T-cell colonies expressing either gamma delta or alpha beta T-cell receptor: role of accessory molecules on HLA-unrestricted killing of virus-infected targets.
Maccario R; Comoli P; Percivalle E; Montagna D; Locatelli F; Gerna G
Immunology; 1995 May; 85(1):49-56. PubMed ID: 7635521
[TBL] [Abstract][Full Text] [Related]
22. Role of interferon in human natural killer activity against target cells infected with HSV-1.
Bishop GA; Glorioso JC; Schwartz SA
J Immunol; 1983 Oct; 131(4):1849-53. PubMed ID: 6194217
[TBL] [Abstract][Full Text] [Related]
23. Native and recombinant herpes simplex virus type 1 envelope proteins induce human immune T-lymphocyte responses.
Torseth JW; Cohen GH; Eisenberg RJ; Berman PW; Lasky LA; Cerini CP; Heilman CJ; Kerwar S; Merigan TC
J Virol; 1987 May; 61(5):1532-9. PubMed ID: 3033279
[TBL] [Abstract][Full Text] [Related]
24. Helper activity in antigen-specific antibody production mediated by CD4+ human cytotoxic T cell clones directed against herpes simplex virus.
Yasukawa M; Inatsuki A; Kobayashi Y
J Immunol; 1988 May; 140(10):3419-25. PubMed ID: 2452188
[TBL] [Abstract][Full Text] [Related]
25. Enhanced lysis of herpes simplex virus type 1-infected mouse cell lines by NC and NK effectors.
Colmenares C; Lopez C
J Immunol; 1986 May; 136(9):3473-80. PubMed ID: 2420891
[TBL] [Abstract][Full Text] [Related]
26. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens.
Yasukawa M; Zarling JM
J Immunol; 1984 Jul; 133(1):422-7. PubMed ID: 6609990
[TBL] [Abstract][Full Text] [Related]
27. The role of natural killer cells and interferon in resistance to acute infection of mice with herpes simplex virus type 1.
Bukowski JF; Welsh RM
J Immunol; 1986 May; 136(9):3481-5. PubMed ID: 2420892
[TBL] [Abstract][Full Text] [Related]
28. Leukocyte migration inhibitory factor in HSV infections.
Centifanto YM; Zam ZS; McNeill JI; Kaufman HE
Invest Ophthalmol Vis Sci; 1978 Sep; 17(9):863-8. PubMed ID: 212384
[TBL] [Abstract][Full Text] [Related]
29. Immune specific production of interferon by human T cells in combined macrophage-lymphocyte cultures in response to Herpes simplex antigen.
Valle MJ; Bobrove AM; Strober S; Merigan TC
J Immunol; 1975 Jan; 114(1 Pt 2):435-41. PubMed ID: 46881
[TBL] [Abstract][Full Text] [Related]
30. Cell-mediated immune responses in patients with recurrent Herpes Simplex infections. II. Infection-associated deficiency of lymphokine production in patients with recurrent herpes labialis or herpes progenitalis.
O'Reilly RJ; Chibbaro A; Anger E; Lopez C
J Immunol; 1977 Mar; 118(3):1095-1102. PubMed ID: 191524
[TBL] [Abstract][Full Text] [Related]
31. [Comparison of complement fixation and Tzanck smear tests for the diagnosis of herpes labialis].
Yurdakul C; Ozcan K; Aksungur L; Köksal F
Mikrobiyol Bul; 1986 Apr; 20(2):84-90. PubMed ID: 3022117
[TBL] [Abstract][Full Text] [Related]
32. Antibody-dependent cell-mediated cytotoxicity to target cells infected with type 1 and type 2 herpes simplex virus.
Shore SL; Black CM; Melewicz FM; Wood PA; Nahmias AJ
J Immunol; 1976 Jan; 116(1):194-201. PubMed ID: 173757
[TBL] [Abstract][Full Text] [Related]
33. Immunological parameters in multiple sclerosis patients with special reference to the herpes virus group.
Haahr S; Møller-Larsen A; Pedersen E
Clin Exp Immunol; 1983 Feb; 51(2):197-206. PubMed ID: 6188564
[TBL] [Abstract][Full Text] [Related]
34. Spleen cell-mediated cytotoxicity of hamster cells transformed by Herpes simplex virus: evidence for virus-specific membrane antigen.
Lausch RN; Jones C; Christie D; Hay KA; Rapp F
J Immunol; 1975 Jan; 114(1 Pt 2):459-65. PubMed ID: 163859
[TBL] [Abstract][Full Text] [Related]
35. Alternative mechanisms of natural killer cell activation during herpes simplex virus infection.
Paya CV; Schoon RA; Leibson PJ
J Immunol; 1990 Jun; 144(11):4370-5. PubMed ID: 2160501
[TBL] [Abstract][Full Text] [Related]
36. Impaired in vitro interferon, blastogenic, and natural killer cell responses to viral stimulation in acquired immune deficiency syndrome.
Hersh EM; Gutterman JU; Spector S; Friedman H; Greenberg SB; Reuben JM; LaPushin R; Matza M; Mansell PW
Cancer Res; 1985 Jan; 45(1):406-10. PubMed ID: 2578099
[TBL] [Abstract][Full Text] [Related]
37. Detection of HSV-1-induced lymphokine production in human cells by a direct indicator cell addition assay.
Clouse KA; Bach FH; Orosz CG
J Immunol; 1984 Jun; 132(6):2961-7. PubMed ID: 6327812
[TBL] [Abstract][Full Text] [Related]
38. Neuroendocrine hormones suppress macrophage-mediated lysis of herpes simplex virus-infected cells.
Koff WC; Dunegan MA
J Immunol; 1986 Jan; 136(2):705-9. PubMed ID: 3001183
[TBL] [Abstract][Full Text] [Related]
39. Studies on human epidermal Langerhans' cells: II. Activation of human T lymphocytes to herpes simplex virus.
Braathen LR; Berle E; Mobech-Hanssen U; Thorsby E
Acta Derm Venereol; 1980; 60(5):381-7. PubMed ID: 6162307
[TBL] [Abstract][Full Text] [Related]
40. Herpes simplex virus-specific immune responses in subjects with frequent and infrequent orofacial recrudescences.
McKenna DB; Neill WA; Norval M
Br J Dermatol; 2001 Mar; 144(3):459-64. PubMed ID: 11259999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
